Live Breaking News & Updates on Guillame Van Renterghem

Stay updated with breaking news from Guillame van renterghem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Vietnam, Strengthening Global IP Portfolio

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Vietnam, Strengthening Global IP Portfolio
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , Israel , Sydney , New-south-wales , Australia , China , Vietnam , Republic-of , Japan , United-states , Jordyn-temperato , James-graham

Recce Pharmaceuticals Provides Additional Positive Update on Patients Treated Under "Special Access Scheme"

Recce Pharmaceuticals Provides Additional Positive Update on Patients Treated Under "Special Access Scheme"
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sydney , New-south-wales , Australia , United-states , Jordyn-temperato , Andrew-geddes , Keflex-cefalexin , Guillame-van-renterghem , James-graham , Recce-pharmaceuticals , Lifesci-communications , Therapeutic-goods-administration

Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections

Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Sydney , New-south-wales , Australia , United-states , Jordyn-temperato , Andrew-geddes , Guillame-van-renterghem , James-graham , Lifesci-communications , Recce-pharmaceuticals-ltd , Recce-pharmaceuticals , Research-unit

Recce Pharmaceuticals Completes Stage 1 Data Analysis of

Patients with bacterial infections successfully treated with RECCE® 327 (R327)Deadly bacterial pathogens treated with R327 include those identified by the. ....

Sydney , New-south-wales , Australia , United-states , Australian , Andrew-geddes , Jordyn-temperato , James-graham , Guillame-van-renterghem , Therapeutic-goods-administration , Lifesci-communications , World-health-organization-priority-pathogen

Recce Pharmaceuticals Provides Positive Update on Patients Treated with RECCE® 327 Under "Special Access Scheme"

Figure 1 Patient Case Study Example A Figure 2 Patient Case Study Example B Figure 3 Clearing in a lawn of Escherichia coli (E. coli) on solid LB-agar media. Table 1 Table 1 RECCE® 327 as a gel formulation (R327G) demonstrated a positive clinical response in the treatment of multiple antibiotic-resistant infections under Therapeutic Goods Administration (TGA) Special Access Scheme (SAS) Category AIn an ex-vivo burn wound study, R327G showed a 4 to 5-log reduction (>99.99%) against Methicillin-re ....

Sydney , New-south-wales , Australia , San-diego , California , United-states , Andrew-geddes , Jordyn-temperato , James-graham , Guillame-van-renterghem , World-health-organization-priority-pathogen , Therapeutic-goods-administration